Trials / Completed
CompletedNCT00329615
Insulin Treatment in Cancer Cachexia
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 135 (planned)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 25 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.
Detailed description
Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic efficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulatard, flexpen |
Timeline
- Start date
- 2000-01-01
- Completion
- 2005-09-01
- First posted
- 2006-05-25
- Last updated
- 2009-08-21
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00329615. Inclusion in this directory is not an endorsement.